A practical reference on REV-ERB agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-07-20 and is reviewed periodically as new material appears.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water; stock solutions use organic solvent. |
| Storage | -20°C, desiccated, protected from light | Limits hydrolysis and photodegradation. |
| Analytical method | HPLC-UV/MS | Used for identity and purity assessment. |
| Synonyms | SR9009, Stenabolic | Naming varies by supplier. |
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
=== Structure-activity relationships === In a virtual screen for novel agonists, a structure-activity relationship was determined from the most potent compounds ('hits') identified. These hits contained a pyrazolo[3,4-d]pyrimidine core (shown in figure 5), which is important for potency toward the 5-HT2C receptors. Compounds with maximum potency featured two substituents linked to the core structure. The first substituent is a piperazine ring, containing a small hydrophobic group; the second substituent is a phenyl part containing a halogen- and/or oxygen-containing side chain (electronegative groups), see derivatives 1 and 2 in figure 5. Addition of aromatic groups to the piperazine ring reduces potency (derivative 4 in figure 5) and the absence of the piperazine ring or substitution with other aliphatic- or cyclic groups reduces potency as well (derivatives 5 and 6 in figure 5).
=== Tizard committee === The need to research better forms of air defense prompted Harry Wimperis to press for the formation of a study group to consider new concepts. Lord Londonderry, then Secretary of State for Air, approved the formation of the Committee for the Scientific Survey of Air Defence in November 1934, asking Henry Tizard to chair the group, which thus became better known to history as the Tizard Committee. When Wimperis sought an expert in radio to help judge the death-ray concept, he was naturally directed to Watt. He wrote to Watt "on the practicability of proposals of the type colloquially called 'death ray'". The two met on 18 January 1935, and Watt promised to look into the matter. Watt turned to Wilkins for help but wanted to keep the underlying question a secret. He asked Wilkins to calculate what sort of radio energy would be needed to raise the temperature of 8 imperial pints (4.5 L) of water at a distance of 5 kilometres (3.1 mi) from 98 to 105 °F (37 to 41 °C). To Watt's bemusement, Wilkins immediately surmised this was a question about a death ray. He made a number of back-of-the-envelope calculations demonstrating the amount of energy needed would be impossible given the state of the art in electronics. According to R. V.
I am myself a Christian, a member of a community that preserves an ancient heritage of great literature and great music, provides help and counsel to young and old when they are in trouble, educates children in moral responsibility, and worships God in its own fashion. But I find Polkinghorne's theology altogether too narrow for my taste. I have no use for a theology that claims to know the answers to deep questions but bases its arguments on the beliefs of a single tribe. I am a practicing Christian but not a believing Christian. To me, to worship God means to recognize that mind and intelligence are woven into the fabric of our universe in a way that altogether surpasses our comprehension. Accepting the Templeton Prize, he said that
Sources: en.wikipedia.org
On 19 September, Trump announced that another vessel allegedly carrying drugs had been destroyed in the Caribbean and that three people had been killed; Trump stated that the vessel was "affiliated with a Designated Terrorist Organization conducting narcotrafficking in the USSOUTHCOM area of responsibility", but did not specify where within the United States Southern Command the strike occurred, the country of origin, or the alleged criminal affiliation. The Dominican Republic later announced that, under its National Directorate for Drug Control and the Dominican Navy, it had cooperated with the US Navy to locate the boat, which was about 80 nautical miles (130 km) south of Dominican-controlled Beata Island. After the boat was destroyed the Dominican Navy salvaged 377 packages of cocaine amounting to 1,000 kilograms (2,200 lb). The Directorate stated that "This is the first time in history that the United States and the Dominican Republic carry out a joint operation against narco terrorism in the Caribbean". Reuters reported that there was a previously unannounced strike on 16 October 2025, which included survivors. The US alleged that the vessel struck was a narco-submarine. Two people were killed and two survived. The survivors were rescued and detained on a US Navy ship. By 19 October, both were repatriated to their respective countries of origin, Colombia and Ecuador. On 17 October, a strike in international waters on an alleged Colombian National Liberation Army (ELN) drug vessel killed an additional three people.
== Data analysis == Data analysis is generally challenging for DIA methods as the resulting fragment ion spectra are highly multiplexed. In DIA spectra therefore the direct relation between a precursor ion and its fragment ions is lost since the fragment ions in DIA spectra may potentially result from multiple precursor ions (any precursor ion present in the m/z range from which the DIA spectrum was derived). One approach to DIA data analysis attempts to use database-based search engines used in data-dependent acquisition to search the produced multiplexed spectra. This approach can be improved by assigning individual fragment ion to precursor ions observed in precursor ion scans, using the elution profile of the fragment ions and the precursor ions, and then searching the resulting "pseudo-spectra". A second approach to DIA data analysis is based on a targeted analysis, also known as SWATH-MS (Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra). This approach uses targeted extraction of fragment ion traces directly for identification and quantification without an explicit attempt to de-multiplex the DIA fragment ion spectra.
The period in the late 1970s and early 1980s showed an intensive reawakening of Cold War tensions and conflicts. Tensions greatly increased between the major powers with both sides becoming more militant. Diggins says, "Reagan went all out to fight the second cold war, by supporting counterinsurgencies in the third world." Cox says, "The intensity of this 'second' Cold War was as great as its duration was short."
== Performance art == While living in London, Gibson met many performance artists at the Brixton Artists Collective. He did his first performance piece in Reading on 4 January 1986. He walked on the High Street with a dog carrying a sign which said: "Wanted: legally preserved human limbs and human fetuses". He tried to do the same piece again in Brighton on 25 January 1986, but he was arrested and convicted of behaviour likely to cause a breach of the peace. Subsequent performance pieces included standing in front of the Director of Public Prosecutions office in London with a live rat in front of his face, enabling people to kill live insects in Plymouth (where he was arrested but released without charge), and questioning the killing of slugs in Vancouver, Canada.
Sources: en.wikipedia.org
prophase The first stage of cell division in both mitosis and meiosis, occurring after interphase and before prometaphase, during which the DNA of the chromosomes is condensed into chromatin, the nucleolus disintegrates, centrosomes move to opposite ends of the cell, and the mitotic spindle forms.
Azvudine is an antiviral drug which acts as a reverse transcriptase inhibitor. It was discovered for the treatment of hepatitis C and has since been investigated for use against other viral diseases such as AIDS and COVID-19, for which it was granted conditional approval in China. Azvudine was first discovered in 2007. It costs 350 Chinese yuan per 7 days for COVID, as of November 2022.
=== 25 July === Russia took the village of Yasnobrodivka in Donetsk Oblast. Russian forces managed to nearly surround two battalions of the Ukrainian 31st Mechanized Brigade near Prohres. Later, according to DeepState, the 31st Mechanized Brigade broke out of the encirclement on the Pokrovsk axis. In Russia, the governor of Belgorod Oblast claimed that one person was killed and two others were injured by Ukrainian shelling in Shebekino. Romanian authorities said that debris from a Russian drone was recovered from the border town of Plauru following an air attack on Izmail. Denmark and the Netherlands pledged to deliver 14 Leopard 2A4 tanks to Ukraine, according to Dutch Defense Minister Ruben Brekelmans. HUR special forces attacked Russian forces at the Kuweires airbase in Syria, destroying an electronic warfare station.
Sources: en.wikipedia.org
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.
The solid is generally kept cold, dry, and protected from light. Solutions are often frozen in single-use aliquots to reduce repeated freeze-thaw cycles.
It indicates a material sold for laboratory study, not for human use. The label does not guarantee pharmaceutical purity, sterility, or regulatory approval.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.